The Gross Margin of Hyundai Pharmaceutical Co Ltd (004310.KS) is 41.75%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-11-30 | 41.75% |
| 2023-11-30 | 42.37% |
| 2022-11-30 | 42.31% |
| 2021-11-30 | 40.28% |
| 2020-11-30 | 43.86% |
| 2019-11-30 | 47.30% |
| 2018-11-30 | 46.23% |
| 2017-11-30 | 47.50% |
| 2016-11-30 | 48.66% |
| 2015-11-30 | 38.49% |